Tata India Innovation Fund

The Tata India Innovation Fund has delivered a 1-year SIP XIRR of 3.76%, which is significantly below the category average of 14.1% and underperforms the NIFTY 50 benchmark on a point-to-point basis (Fund CAGR 5.87% vs Benchmark CAGR -2.9% over 1 year). Over longer horizons, the fund's CAGR remains positive but modest, ranging from 0.28% (12Y) to 1.14% (3Y), while the benchmark has been negative, indicating relative outperformance in absolute terms. The fund has generated positive alpha across all periods, with the highest 1-year alpha of 8.35%, but the absolute returns are low, reflecting a challenging market environment.

The fund exhibits a maximum drawdown of -0.18% with a recovery period of 165 days, indicating relatively shallow but prolonged drawdowns, and has experienced 2 drawdown events exceeding 10%. The Calmar ratio for 1 year is 0.1557, suggesting modest risk-adjusted returns relative to the maximum drawdown. With a beta close to 1 (0.96-0.99) across all periods, the fund's volatility is in line with the market, but its downside capture (83.82% over 1Y) is lower than upside capture (95.13%), indicating some downside protection.

The fund holds a diversified portfolio of 57 stocks, with top 10 holdings accounting for approximately 30.74% of NAV, led by ICICI Bank (4.74%), Reliance Industries (3.42%), and Axis Bank (3.36%). Sector concentration is notable in Banks (17.9%), Healthcare Services (11.2%), and Pharmaceuticals (7.3%), which together represent over 36% of the portfolio. The holdings span multiple sectors including telecom, retail, and automobiles, but the fund's thematic focus on innovation is not clearly reflected in the top holdings, which are largely large-cap names.

The fund's 1-year XIRR of 3.76% is substantially below the category average of 14.1%, placing it in the lower quartile of sectoral/thematic funds. Over longer periods, the fund's performance is also weak, with 3Y and 5Y XIRRs not provided but implied by the low CAGRs, which are far below the category averages of 16.82% and 16.95% respectively. The fund has delivered positive alpha versus the benchmark across all periods, but the absolute returns are low, and the consistency of underperformance relative to peers is a concern.

This fund is suitable for investors with a high risk tolerance and a long-term investment horizon (5+ years) who are willing to accept below-average returns in exchange for potential innovation-driven growth. Given the current low returns and high category average, it may not be ideal for investors seeking immediate income or those with a low risk appetite. Investors should be prepared for volatility and the possibility of underperformance relative to sectoral peers, and should consider this fund as a satellite allocation within a diversified portfolio.

• Positive alpha over all time periods, with a 1-year alpha of 8.35% versus the NIFTY 50.
• Lower downside capture (83.82% over 1Y) than upside capture (95.13%), indicating some resilience in down markets.
• Low expense ratio of 0.68% for a direct plan, which is cost-efficient for investors.

• Significant underperformance versus the category average, with 1Y XIRR of 3.76% versus 14.1% for peers.
• Low absolute returns across all periods, with 3Y CAGR of only 1.14% and 5Y CAGR of 0.68%, which may not keep pace with inflation.